Privia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at Needham & Company LLC

Needham & Company LLC began coverage on shares of Privia Health Group (NASDAQ:PRVA) in a report released on Friday, MarketBeat.com reports. The firm set a “buy” rating and a $25.00 price target on the stock. Needham & Company LLC’s target price would indicate a potential upside of 19.45% from the company’s previous close.

A number of other research firms have also issued reports on PRVA. Stephens reissued an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. KeyCorp initiated coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price target on the stock. Truist Financial increased their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Macquarie initiated coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective for the company. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $24.88.

Privia Health Group Trading Up 3.1 %

NASDAQ:PRVA opened at $20.93 on Friday. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $23.78. The firm has a market capitalization of $2.51 billion, a price-to-earnings ratio of 209.32, a PEG ratio of 5.45 and a beta of 0.85. The business’s fifty day moving average price is $20.90 and its 200 day moving average price is $19.40.

Institutional Trading of Privia Health Group

Several large investors have recently modified their holdings of the company. Nordea Investment Management AB raised its holdings in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after acquiring an additional 86,910 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Privia Health Group by 8.4% in the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after purchasing an additional 14,641 shares during the period. Franklin Resources Inc. increased its stake in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after purchasing an additional 28,480 shares during the period. Virtu Financial LLC acquired a new position in shares of Privia Health Group during the 3rd quarter worth about $263,000. Finally, Neo Ivy Capital Management bought a new stake in Privia Health Group during the 3rd quarter valued at approximately $66,000. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.